This study used SS-OCTA to evaluate the PD of SCP, DCP, CC), and MLC, as well as the CVI in the central, mid-peripheral, and peripheral fields of patients with RP carrying mutations in the CYP4V2, EYS, PRPH2, RPGR, or USH2A genes. This evidence concerns the gene CYP4V2 and retinitis pigmentosa 1.